ESPE Yearbook of Paediatric Endocrinology

World J Diabetes 2020; 11: 358–369. https://dx.doi.org/10.4239/wjd.v11.i8.358– To assess access to insulin delivery devices and HbA1c in 41 countries supported by the Life for a Child (LFAC) program– Syringes (83.1%), insulin pens (16.7%) and pumps (0.2%) were used for insulin delivery– If supplies were not donated, there was variable access to HbA1c testing within publi...

Lancet Diabetes Endocrinol 2019; 7: 150–60. DOI 10.1016/S2213-8587(18)30074-3• Access to blood glucose monitoring is often poor in resource-limited settings.• The authors analyse the reasons for suboptimal access, with a focus on cost, availability, system accuracy, competitive bidding, technological trends, and non-financial barriers. Urine gl...

grahamo@diabetesnsw.com.au Diabetes Res Clin Pract 2022, 183:109083. doi: 10.1016/j.diabres.2021.109083Brief Summary: The incidence of Type 1 diabetes (T1D) in children and adolescents is increasing in many nations. The 10th edition of the International Diabetes Federation Atlas reports that an estimated 108,300 youth aged < 15 years a...